Implications of protein flexibility for drug discovery

被引:563
作者
Teague, SJ [1 ]
机构
[1] AstraZeneca R&D Charnwood, Loughborough LE11 5RH, Leics, England
关键词
D O I
10.1038/nrd1129
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Proteins are in constant motion between different conformational states with similar energies. This has often been ignored in drug design. However, protein flexibility is fundamental to understanding the ways in which drugs exert biological effects, their binding-site location, binding orientation, binding kinetics, metabolism and transport. Protein flexibility allows increased affinity to be achieved between a drug and its target. This is crucial, because the lipophilicity and number of polar interactions allowed for an oral drug is limited by absorption, distribution, metabolism and toxicology considerations.
引用
收藏
页码:527 / 541
页数:15
相关论文
共 94 条
  • [1] ALLOSTERIC MODIFIERS OF HEMOGLOBIN - 2-[4-[[(3,5-DISUBSTITUTED ANILINO)CARBONYL]METHYL]PHENOXY]-2-METHYLPROPIONIC ACID-DERIVATIVES THAT LOWER THE OXYGEN-AFFINITY OF HEMOGLOBIN IN RED-CELL SUSPENSIONS, IN WHOLE-BLOOD, AND INVIVO IN RATS
    ABRAHAM, DJ
    WIREKO, FC
    RANDAD, RS
    POYART, C
    KISTER, J
    BOHN, B
    LIARD, JF
    KUNERT, MP
    [J]. BIOCHEMISTRY, 1992, 31 (38) : 9141 - 9149
  • [2] Molecular recognition of cyclic urea HIV-1 protease inhibitors
    Ala, PJ
    DeLoskey, RJ
    Huston, EE
    Jadhav, PK
    Lam, PYS
    Eyermann, CJ
    Hodge, CN
    Schadt, MC
    Lewandowski, FA
    Weber, PC
    McCabe, DD
    Duke, JL
    Chang, CH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (20) : 12325 - 12331
  • [3] Binding of small molecules to an adaptive protein-protein interface
    Arkin, MR
    Randal, M
    DeLano, WL
    Hyde, J
    Luong, TN
    Oslob, JD
    Raphael, DR
    Taylor, L
    Wang, J
    McDowell, RS
    Wells, JA
    Braisted, AC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) : 1603 - 1608
  • [4] MECHANISM OF INHIBITION OF CHOLINESTERASES BY HUPERZINE-A
    ASHANI, Y
    PEGGINS, JO
    DOCTOR, BP
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (02) : 719 - 726
  • [5] THIENOTHIOPYRAN-2-SULFONAMIDES - NOVEL TOPICALLY ACTIVE CARBONIC-ANHYDRASE INHIBITORS FOR THE TREATMENT OF GLAUCOMA
    BALDWIN, JJ
    PONTICELLO, GS
    ANDERSON, PS
    CHRISTY, ME
    MURCKO, MA
    RANDALL, WC
    SCHWAM, H
    SUGRUE, MF
    SPRINGER, JP
    GAUTHERON, P
    GROVE, J
    MALLORGA, P
    VIADER, MP
    MCKEEVER, BM
    NAVIA, MA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (12) : 2510 - 2513
  • [6] Protein folding - Making a network of hydrophobic clusters
    Baldwin, RL
    [J]. SCIENCE, 2002, 295 (5560) : 1657 - 1658
  • [7] The 1.8-Å crystal structure of a matrix metallaproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition
    Brandstetter, H
    Grams, F
    Glitz, D
    Lang, A
    Huber, R
    Bode, W
    Krell, HW
    Engh, RA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (20) : 17405 - 17412
  • [8] Molecular basis of agonism and antagonism in the oestrogen receptor
    Brzozowski, AM
    Pike, ACW
    Dauter, Z
    Hubbard, RE
    Bonn, T
    Engstrom, O
    Ohman, L
    Greene, GL
    Gustafsson, JA
    Carlquist, M
    [J]. NATURE, 1997, 389 (6652) : 753 - 758
  • [9] Designing non-peptide peptidomimetics in the 21st century: Inhibitors targeting conformational ensembles
    Bursavich, MG
    Rich, DH
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (03) : 541 - 558
  • [10] Protein flexibility and drug design: how to hit a moving target
    Carlson, HA
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2002, 6 (04) : 447 - 452